• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用莫特沙芬镥介导的光动力疗法对正常犬前列腺在732纳米处的体内光学特性研究。

In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy.

作者信息

Zhu Timothy C, Hahn Stephen M, Kapatkin Amy S, Dimofte Andreea, Rodriguez Carmen E, Vulcan Teodor G, Glatstein Eli, Hsi R Alex

机构信息

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Photochem Photobiol. 2003 Jan;77(1):81-8. doi: 10.1562/0031-8655(2003)077<0081:ivopon>2.0.co;2.

DOI:10.1562/0031-8655(2003)077<0081:ivopon>2.0.co;2
PMID:12856887
Abstract

The optical properties (absorption [mu(a)], transport scattering [mu('s)] and effective attenuation [mu(eff)] coefficients) of normal canine prostate were measured in vivo using interstitial isotropic detectors. Measurements were made at 732 nm before, during and after motexafin lutetium (MLu)-mediated photodynamic therapy (PDT). They were derived by applying the diffusion theory to the in vivo peak fluence rates measured at several distances (3, 6, 9, 12 and 15 mm) from the central axis of a 2.5 cm cylindrical diffusing fiber (CDF). Mu(a) and mu('s) varied between 0.03-0.58 and 1.0-20 cm(-1), respectively. Mu(a) was proportional to the concentration of MLu.Mu(eff) varied between 0.33 and 4.9 cm(-1) (mean 1.3 +/- 1.1 cm(-1)), corresponding to an optical penetration depth (8 = 1/(mu(eff)) of 0.5-3 cm (mean 1.3 +/- 0.8 cm). The mean light fluence rate at 0.5 cm from the CDF was 126 +/- 48 mW/cm2 (N = 22) when the total power from the fiber was 375 mW (150 mW/cm). This study showed significant inter- and intraprostatic differences in the optical properties, suggesting that a real-time dosimetry measurement and feedback system for monitoring light fluences during treatment should be advocated for future PDT studies. However, no significant changes were observed before, during and after PDT within a single treatment site.

摘要

使用组织间各向同性探测器在体内测量了正常犬前列腺的光学特性(吸收系数[μ(a)]、输运散射系数[μ('s)]和有效衰减系数[μ(eff)])。在莫替沙芬镥(MLu)介导的光动力疗法(PDT)之前、期间和之后,于732 nm波长进行了测量。这些系数是通过将扩散理论应用于在距2.5 cm圆柱形扩散光纤(CDF)中心轴几个距离(3、6、9、12和15 mm)处测量的体内峰值注量率而得出的。μ(a)和μ('s)分别在0.03 - 0.58和1.0 - 20 cm⁻¹之间变化。μ(a)与MLu的浓度成正比。μ(eff)在0.33至4.9 cm⁻¹之间变化(平均为1.3 ± 1.1 cm⁻¹),对应的光穿透深度(δ = 1/μ(eff))为0.5 - 3 cm(平均为1.3 ± 0.8 cm)。当光纤的总功率为375 mW(150 mW/cm)时,距CDF 0.5 cm处的平均光注量率为126 ± 48 mW/cm²(N = 22)。本研究表明前列腺内部和之间的光学特性存在显著差异,这表明在未来的PDT研究中应提倡用于监测治疗期间光注量的实时剂量测量和反馈系统。然而,在单个治疗部位的PDT之前、期间和之后未观察到显著变化。

相似文献

1
In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy.使用莫特沙芬镥介导的光动力疗法对正常犬前列腺在732纳米处的体内光学特性研究。
Photochem Photobiol. 2003 Jan;77(1):81-8. doi: 10.1562/0031-8655(2003)077<0081:ivopon>2.0.co;2.
2
Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy.在介导光动力疗法中测量的人体前列腺在732纳米处的光学特性。
Photochem Photobiol. 2005 Jan-Feb;81(1):96-105. doi: 10.1562/2004-06-25-RA-216.
3
Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy.在莫替沙芬镥介导的光动力疗法期间对人体前列腺体内的光分布、光学特性、药物浓度和组织氧合进行测定。
J Photochem Photobiol B. 2005 Jun 1;79(3):231-41. doi: 10.1016/j.jphotobiol.2004.09.013. Epub 2004 Dec 2.
4
In vivo light dosimetry for motexafin lutetium-mediated PDT of recurrent breast cancer.用于莫替沙芬镥介导的复发性乳腺癌光动力疗法的体内光剂量测定
Lasers Surg Med. 2002;31(5):305-12. doi: 10.1002/lsm.10115.
5
In vivo reflectance measurement of optical properties, blood oxygenation and motexafin lutetium uptake in canine large bowels, kidneys and prostates.犬类大肠、肾脏和前列腺光学特性、血液氧合及莫替沙芬镥摄取的体内反射率测量。
Phys Med Biol. 2002 Mar 21;47(6):857-73.
6
Changes in in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy.光动力疗法期间正常犬前列腺的体内光学特性和光分布变化
Radiat Res. 1997 Jan;147(1):86-91. doi: 10.2307/3579447.
7
Photodynamic therapy with motexafin lutetium for rectal cancer: a preclinical model in the dog.用莫替沙芬镥进行光动力疗法治疗直肠癌:犬的临床前模型
J Surg Res. 2006 Oct;135(2):323-30. doi: 10.1016/j.jss.2006.01.020. Epub 2006 May 2.
8
Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.镥莫替沙芬介导的间质光动力疗法用于局部复发性前列腺癌患者的I期试验的更新结果。
J Environ Pathol Toxicol Oncol. 2006;25(1-2):373-87. doi: 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.230.
9
Transperineal in vivo fluence-rate dosimetry in the canine prostate during SnET2-mediated PDT.在SnET2介导的光动力疗法期间对犬前列腺进行经会阴体内注量率剂量测定。
Phys Med Biol. 2004 Jul 21;49(14):3209-25. doi: 10.1088/0031-9155/49/14/014.
10
Photodynamic therapy in the canine prostate using motexafin lutetium.使用莫特沙芬镥对犬前列腺进行光动力治疗。
Clin Cancer Res. 2001 Mar;7(3):651-60.

引用本文的文献

1
In vivo spectroscopic evaluation of human tissue optical properties and hemodynamics during HPPH-mediated photodynamic therapy of pleural malignancies.在 HPPH 介导的胸膜恶性肿瘤光动力治疗过程中对人体组织光学特性和血液动力学的体内光谱评估。
J Biomed Opt. 2022 Oct;27(10). doi: 10.1117/1.JBO.27.10.105006.
2
Optimized Cylindrical Diffuser Powers for Interstitial PDT Breast Cancer Treatment Planning: A Simulation Study.优化的圆柱形扩散器功率用于间质光动力疗法治疗乳腺癌的计划:一项模拟研究。
Biomed Res Int. 2020 Mar 23;2020:2061509. doi: 10.1155/2020/2061509. eCollection 2020.
3
Photosensitizers in prostate cancer therapy.
前列腺癌治疗中的光敏剂。
Oncotarget. 2017 May 2;8(18):30524-30538. doi: 10.18632/oncotarget.15496.
4
On the in vivo photochemical rate parameters for PDT reactive oxygen species modeling.关于用于光动力疗法活性氧建模的体内光化学速率参数。
Phys Med Biol. 2017 Mar 7;62(5):R1-R48. doi: 10.1088/1361-6560/62/5/R1. Epub 2017 Feb 6.
5
Optimization of light sources for prostate photodynamic therapy.前列腺光动力治疗光源的优化
Proc SPIE Int Soc Opt Eng. 2005 Apr 22;5689:186-197. doi: 10.1117/12.590343.
6
light dosimetry of interstitial PDT of human prostate.人类前列腺间质光动力疗法的光剂量测定
Proc SPIE Int Soc Opt Eng. 2006 Jan 21;6139. doi: 10.1117/12.646220.
7
A fast heterogeneous algorithm for light fluence rate for prostate photodynamic therapy.一种用于前列腺光动力治疗光通量率的快速非均匀算法。
Proc SPIE Int Soc Opt Eng. 2010 Mar 2;7551. doi: 10.1117/12.843000.
8
Characterization of tissue optical properties for prostate PDT using interstitial diffuse optical tomography.使用组织间扩散光学断层扫描对前列腺光动力疗法的组织光学特性进行表征。
Proc SPIE Int Soc Opt Eng. 2012 Jan 21;8210. doi: 10.1117/12.908294.
9
Pre-clinic study of uniformity of light blanket for intraoperative photodynamic therapy.术中光动力治疗用轻薄光导纤维毯均匀性的临床前研究
Proc SPIE Int Soc Opt Eng. 2010 Jan 23;7551. doi: 10.1117/12.842809.
10
Reconstruction of optical properties using a diffusion model for interstitial diffuse optical tomography.使用扩散模型进行组织间漫射光学层析成像的光学特性重建。
Proc SPIE Int Soc Opt Eng. 2009 Feb 18;7164:71640P. doi: 10.1117/12.809065.